Emerge Australia Incorporated
This organization has already been registered
Someone in your organization has already registered and setup an account. would you like to join their team?Profile owner : f*****e@e****e.o*g.au
Mission Statement
Our mission - To support, provide information and advocacy for people associated with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Our vision - Universal awareness and acknowledgement of ME/CFS as a medical condition. Our values - To serve the best interests of people affected by ME/CFS with integrity, compassion and empathy.
About This Cause
Emerge Australia is a national patient organisation providing information, support and advocacy for people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Our work gives hope and help to more than 250,000 Australians living with ME/CFS. The impacts of ME/CFS can be devastating, leaving 25% of patients housebound or bedbound, with many people unable to work or participate in community life. People living with ME/CFS often feel invisible due to the unknown cause of the condition, lack of effective treatment options and limited community awareness, leading many to 'go missing' from their own lives. In order to continue our essential work, Emerge Australia relies on generous support from the community as we continue to lobby for increased public awareness and funding for biomedical research. Our work - We provide expertise on issues to do with ME/CFS at a national level - We host a range of community, national and international events that aim to increase awareness of ME/CFS as a biomedical illness - We provide a variety of resources, as well as news and updates, for people living with ME/CFS - We provide a telehealth nurse service to help meet the needs of people living with ME/CFS - We advocate for systemic reform to improve access to financial and social supports, and to improve access to better healthcare for people living with ME/CFS - We lobby for increases in community support for people with the disease and to drive more biomedical research into ME/CFS